Seek, test, treat: substance-using women in the HIV treatment cascade in South Africa

Wendee M Wechsberg, Charles van der Horst, Jacqueline Ndirangu, Irene A Doherty, Tracy Kline, Felicia A Browne, Jennifer M Belus, Robin Nance, William A Zule, Wendee M Wechsberg, Charles van der Horst, Jacqueline Ndirangu, Irene A Doherty, Tracy Kline, Felicia A Browne, Jennifer M Belus, Robin Nance, William A Zule

Abstract

Background: Women in South Africa who use alcohol and other drugs face multiple barriers to HIV care. These barriers make it difficult for women to progress through each step in the HIV treatment cascade from diagnosis to treatment initiation and adherence. This paper examines correlates of HIV status, newly diagnosed HIV status, and use of antiretroviral therapy (ART).

Methods: Outreach workers recruited sexually active Black African women who used substances in Pretoria as part of a U.S. National Institutes of Health-funded geographically clustered randomized trial examining the effect of an intervention to reduce alcohol and drug use as well as sexual risk behaviors. To address the question of interest in the current investigation, cross-sectional baseline data were used. At study enrollment, all participants (N = 641) completed an interview, and underwent rapid HIV testing and biological drug screening. Those who tested positive for HIV and were eligible for ART were asked about their barriers to initiating or adhering to ART. Bivariate and multivariable logistic regression analyses were conducted to determine correlates of HIV status, newly diagnosed HIV, and ART use.

Results: At enrollment, 55% of participants tested positive for HIV, and 36% of these women were newly diagnosed. In multivariable analyses of the entire sample, women who had completed 10th grade were less likely to be living with HIV (OR 0.69; CI 0.48, 0.99) and those from the inner city were more likely to be living with HIV (OR 1.83; CI 1.26, 2.67). Among HIV-positive participants, women were less likely to be newly diagnosed if they had ever been in substance abuse treatment (OR 0.15; CI 0.03, 0.69) or used a condom at last sex (OR 0.58; CI 0.34, 0.98) and more likely to be newly diagnosed if they were physically assaulted in the past year (OR 1.97; CI 1.01, 3.84). Among women eligible for ART, fewer were likely to be on treatment (by self-report) if they had a positive urine test for opiates or cocaine (OR 0.27; CI 0.09, 0.80).

Conclusions: These results, although cross-sectional, provide some guidance for provincial authorities to address barriers to HIV care for sexually active, substance-using vulnerable women in Pretoria. Targeting the inner city with prevention campaigns, expanding and improving substance abuse treatment programs, linking clients with simultaneous HIV testing and treatment, and targeting women who have experienced sexual assault and violence may help the government achieve the UNAIDS 90-90-90 treatment target. Clinical Trials.gov NCT01497405 registered on December 1, 2011.

Keywords: Alcohol and other drug use; Sexually-active women; Treatment cascade.

Figures

Fig. 1
Fig. 1
HIV cascade for women recruited for the study

References

    1. UN Women. Facts and figures: HIV and AIDS. 6/2016 edn. New York, NY: UN Women; 2016.
    1. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, et al. Antiretroviral therapy for the prevention of HIV-1 transmission. N Engl J Med. 2016;375(9):830–839. doi: 10.1056/NEJMoa1600693.
    1. Das M, Chu PL, Santos GM, Scheer S, Vittinghoff E, McFarland W, Colfax GN. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS ONE. 2010;5(6):e11068. doi: 10.1371/journal.pone.0011068.
    1. Wood E, Kerr T, Marshall BD, Li K, Zhang R, Hogg RS, Harrigan PR, Montaner JS. Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ. 2009;338:b1649. doi: 10.1136/bmj.b1649.
    1. Eaton JW, Johnson LF, Salomon JA, Barnighausen T, Bendavid E, Bershteyn A, Bloom DE, Cambiano V, Fraser C, Hontelez JA, et al. HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med. 2012;9(7):e1001245. doi: 10.1371/journal.pmed.1001245.
    1. UNAIDS: 90-90-90-An ambitious treatment target to help end the AIDS epidemic. Geneva: UNAIDS; 2014.
    1. Hull MW, Wu Z, Montaner JS. Optimizing the engagement of care cascade: a critical step to maximize the impact of HIV treatment as prevention. Curr Opin HIV AIDS. 2012;7(6):579–586. doi: 10.1097/COH.0b013e3283590617.
    1. Volkow ND, Baler RD, Normand JL. The unrealized potential of addiction science in curbing the HIV epidemic. Curr HIV Res. 2011;9(6):393–395. doi: 10.2174/157016211798038605.
    1. Vagenas P, Azar MM, Copenhaver MM, Springer SA, Molina PE, Altice FL. The impact of alcohol use and related disorders on the HIV Continuum of care: a systematic review: alcohol and the HIV continuum of care. Curr HIV/AIDS Rep. 2015;12(4):421–436. doi: 10.1007/s11904-015-0285-5.
    1. Williams B, Wood R, Dukay V, Delva W, Ginsburg D, Hargrove J, Stander M, Sheneberger R, Montaner J, Welte A. Treatment as prevention: preparing the way. J Int AIDS Soc. 2011;14(Suppl 1):S6. doi: 10.1186/1758-2652-14-S1-S6.
    1. WHO: Women’s health In: Fact Sheet No. 334. World Health Organization; 2013. .
    1. Haberer JE, Baeten JM, Campbell J, Wangisi J, Katabira E, Ronald A, Tumwesigye E, Psaros C, Safren SA, Ware NC, et al. Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa. PLoS Med. 2013;10(9):e1001511. doi: 10.1371/journal.pmed.1001511.
    1. Wechsberg WM, Wu LT, Zule WA, Parry CD, Browne FA, Luseno WK, Kline T, Gentry A. Substance abuse, treatment needs and access among female sex workers and non-sex workers in Pretoria, South Africa. Subst Abuse Treat Prev Policy. 2009;4:11. doi: 10.1186/1747-597X-4-11.
    1. Rumptz MH, Tobias C, Rajabiun S, Bradford J, Cabral H, Young R, Cunningham WE. Factors associated with engaging socially marginalized HIV-positive persons in primary care. AIDS Patient Care STDS. 2007;21(Suppl 1):S30–S39.
    1. Tobias CR, Cunningham W, Cabral HD, Cunningham CO, Eldred L, Naar-King S, Bradford J, Sohler NL, Wong MD, Drainoni ML. Living with HIV but without medical care: barriers to engagement. AIDS Patient Care STDS. 2007;21(6):426–434. doi: 10.1089/apc.2006.0138.
    1. Dada S, Erasmus J, Burnhams NH, Parry C, Bhana A, Timol F, Fourie D, Kitshoff D, Nel E, Weimann R. Monitoring alcohol, tobacco and other drug abuse trends in South Africa (July 1996–June 2015): Phase 38. In: SACENDU Research Brief, vol. 18; 2015.
    1. Wechsberg WM, Zule WA, Ndirangu J, Kline TL, Rodman NF, Doherty IA, Novak SP, van der Horst CM. The biobehavioral Women’s Health CoOp in Pretoria, South Africa: study protocol for a cluster-randomized design. BMC Public Health. 1074;2014:14.
    1. Cairncross v De Vos (1876) 6 Buch 5; Steenkamp v Kampfer 1914 CPD 877; Venter v De Burghersdorp Stores 1915 CPD 252; Pleat v Van Staden 1921 OPD 91; Ambaker v African Meat Co 1927 CPD 326; Ochberg v Ochberg’s Estate 1941 CPD 15; Ahmed v Coovadia 1944 TPD 364; Dickens v Daley 1956 1 All SA 329 (N); 1956 2 All SA 197 (N); 1956 2 SA 11 (N); Grand Prix Motors WP (Pty) Ltd v Swart 1976 3 All SA 480 (C); 1976 3 SA 221 (C); Heaton The South African Law of Persons (3 ed) (2008) 115 et seq; Van Heerden, Cockrell and Keightley (eds) Boberg’s Law of Persons and the Family (2 ed) (1999) 474; Van der Vyver and Joubert Persone- en Familiereg 131 et seq; Steyn 1927 SALJ 313; Spiro Parent and Child 249 et seq; De Wet and Van Wyk Kontraktereg en Handelsreg 64–66.
    1. Wechsberg WM, Zule WA, Luseno WK, Kline TL, Browne FA, Novak SP, Ellerson RM. Effectiveness of an adapted evidence-based woman-focused intervention for sex workers and non-sex workers: the Women’s Health Coop in South Africa. J Drug Issues. 2011;41(2):233–252. doi: 10.1177/002204261104100205.
    1. Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG. The Alcohol Use Disorders Identification Test: guidelines for use in primary care. vol. WHO/MSD/MSB/01.6a. Geneva: World Health Organization Department of Mental Health and Substance Dependence; 2001.
    1. Ware JE, Kosinski M, Dewey JE. How to score version 2 of the SF-36. Lincoln, RI: Quality Metric Incorporated; 2000.
    1. Padian NS, Shiboski SC, Jewell NP. Female-to-male transmission of human immunodeficiency virus. JAMA. 1991;266(12):1664–1667. doi: 10.1001/jama.1991.03470120066034.
    1. Gupta GR, Ogden J, Warner A. Moving forward on women’s gender-related HIV vulnerability: the good news, the bad news and what to do about it. Glob Public Health. 2011;6(Suppl 3):S370–S382. doi: 10.1080/17441692.2011.617381.
    1. Stoebenau K, Heise L, Wamoyi J, Bobrova N. Revisiting the understanding of “transactional sex” in sub-Saharan Africa: a review and synthesis of the literature. Soc Sci Med. 2016;168:186–197. doi: 10.1016/j.socscimed.2016.09.023.
    1. Murnane PM, Celum C, Mugo N, Campbell JD, Donnell D, Bukusi E, Mujugira A, Tappero J, Kahle EM, Thomas KK, et al. Efficacy of preexposure prophylaxis for HIV-1 prevention among high-risk heterosexuals: subgroup analyses from a randomized trial. Aids. 2013;27(13):2155–2160. doi: 10.1097/QAD.0b013e3283629037.
    1. Doherty IA, Myers B, Zule WA, Minnis AM, Kline TL, Parry CD, Wechsberg WM. Seek, test and disclose: knowledge of HIV testing and serostatus among high-risk couples in a South African township. Sex Transm Infect. 2016;92(1):5–11. doi: 10.1136/sextrans-2014-051882.
    1. Maughan-Brown B, Lloyd N, Bor J, Venkataramani AS: Changes in self-reported HIV testing during South Africa’s 2010/2011 national testing campaign: gains and shortfalls. J Int AIDS Soc. 2016;19(1).
    1. Dombrowski JC, Simoni JM, Katz DA, Golden MR. Barriers to HIV care and treatment among participants in a public health HIV care relinkage program. AIDS Patient Care STDs. 2015;29(5):279–287. doi: 10.1089/apc.2014.0346.
    1. Proeschold-Bell RJ, Heine A, Pence BW, McAdam K, Quinlivan EB. A cross-site, comparative effectiveness study of an integrated HIV and substance use treatment program. AIDS Patient Care STDS. 2010;24(10):651–658. doi: 10.1089/apc.2010.0073.
    1. Lombard F, Proescholdbell RJ, Cooper K, Musselwhite L, Quinlivan EB. Adaptations across clinical sites of an integrated treatment model for persons with HIV and substance abuse. AIDS Patient Care STDS. 2009;23(8):631–638. doi: 10.1089/apc.2008.0260.
    1. Department of Health . National consolidated guidelines for the prevention of mother-to-child transmission of HIV (PMTCT) and the management of HIV in children, adolescents and adults. Pretoria: Department of Health; 2014.
    1. Kagee A, Remien R, Berkman A, Hoffman S, Campos L, Swartz L. Structural barriers to ART adherence in Southern Africa: challenges and potential ways forward. Glob Public Health. 2011;6(1):83–97. doi: 10.1080/17441691003796387.
    1. UNAIDS: South Africa takes bold step to provide HIV treatment for all. Geneva: UNAIDS; 2016.
    1. Needle R, Fisher DG, Weatherby N, Chitwood D, Brown B, Cesari H, Booth R, Williams ML, Watters J, Andersen M. Reliability of self-reported HIV risk behaviors of drug users. Psychol Addict Behav. 1995;9(4):242. doi: 10.1037/0893-164X.9.4.242.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe